Pashayan, N;
Reisel, D;
Widschwendter, M;
(2016)
Integration of genetic and epigenetic markers for risk stratification: opportunities and challenges.
Personalized Medicine
, 13
(2)
pp. 93-95.
10.2217/pme.15.53.
Preview |
Text
Pashayan et al 2016 Integration of genetic and epigenetic markers.pdf Download (312kB) | Preview |
Abstract
Common genetic susceptibility variants could be used for risk stratification in risk-tailored cancer screening and prevention programmes. Combining genetic variants with environmental risk factors would improve risk stratification. Epigenetic changes are surrogate markers of environmental exposures during individual's lifetime. Integrating epigenetic markers, in lieu of environmental exposure data, with genetic markers would potentially improve risk stratification. Epigenetic changes are reversible and acquired gradually, providing potentials for prevention and early detection strategies. The epigenetic changes are tissue-specific and stage-of-development-specific, raising challenges in choice of sample and timing for evaluation of cancer-associated changes. The Horizon 2020 funded research programme, FORECEE, using empirical data, will investigate the value of integration of epigenomics with genomics for risk prediction and prevention of women-specific cancers.
Archive Staff Only
 |
View Item |
